Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 125† | 137† | 108† | 84† | 167† |
| Net profit | -32 | 8 | -2 | -13 | 40† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| KUNAL NARENDRA GANDHI | Executive Director | June 30, 2026 |
| YOGESH BABULAL SHAH | Executive Director | June 30, 2026 |
| ARCHANA SURENDRA YADAV | Independent Director | June 30, 2026 |
| BABU LAL JAIN | Independent Director | June 30, 2026 |
| NEERAJ GOLAS | Independent Director | June 30, 2026 |
| PRASHANT GODHA | Non-Executive Director | June 30, 2026 |
| SHASHIL PHILIP MENDONSA | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
